Nova Patents
AT398461T

Vaccine for transcutaneous immunization against travellers' diarrhoea

Abstract

Using heat labile toxin whole E. coli (LT) as an immunogen in the manufacture of a vaccine for transcutaneous immunization for the treatment and / or prevention of travelers diarrhea, wherein said immunogen is present in effective amounts to induce an immune response against one or more strains of enterotoxigenic Escherichia coli (ETEC).

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

17 members in 12 offices

This recordMember, by publication datePriority claim2 more offices are in the list below

Priority claims4

Priority claims
DocumentOfficeKindDate
26801601United States of AmericaP
30411001United States of AmericaP
31044701United States of AmericaP
31048301United States of AmericaP

Members17

Family members, oldest first
DocumentOfficeKind
CA2437899A1CanadaA1
WO02064162A2World Intellectual Property Organization (WIPO)A2
WO02064162A3World Intellectual Property Organization (WIPO)A3
EP1372708A2European Patent Office (EPO)A2
US2004146534A1United States of AmericaA1
JP2005504002AJapanA
AU2002250071B2AustraliaB2
EP1372708B1European Patent Office (EPO)B1
AT398461TThis recordAustriaT
DE60227157D1GermanyD1
PT1372708EPortugalE
DK1372708T3DenmarkT3
ES2310201T3SpainT3
US7527802B2United States of AmericaB2
JP2010180228AJapanA
CA2437899CCanadaC
CY1111030T1CyprusT1